CIK 0001661181
- Accelerated filer
Organogenesis Holdings Inc.
Sign in to watch- Ticker
- ORGO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-575-0775
- Business address
- 85 DAN ROAD, CANTON, MA, 02021
- Former names
- Avista Healthcare Public Acquisition Corp.
- 4 Shares withheld for taxes VP and General Counsel gave up 1,975 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 6,265 shares (to pay taxes)
- 4 Shares withheld for taxes VP Health Policy & Contracting gave up 1,770 shares (to pay taxes)
- 4 Grant or award Chief Financial Officer acquired 10,965 shares (grant or award)
- 4 Grant or award VP Health Policy & Contracting acquired 8,260 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 10,782 shares (grant or award)
- 4 Grant or award VP and General Counsel acquired 8,808 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 10,782 shares (grant or award)
- 4 Open-market sale President and CEO sold 106,038 shares at an average $13.28 ($1,408,618)
- 4 Grant or award Director acquired 11,800 shares (grant or award)
- 4 Grant or award Director acquired 11,800 shares (grant or award)
- 4 Grant or award Director acquired 11,800 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 5,396 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President and CEO sold 291,862 shares at an average $13.32 ($3,886,852)
- 4 Open-market sale Director sold 200,000 shares at $3.25 ($650,000)
- 4 Open-market sale Director sold 200,000 shares at $3.25 ($650,000)
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Grant or award Interim CFO acquired 10,700 shares (grant or award)
Page 11 of 17 · 321 filings